8-K

================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                               ------------------

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934


          Date of Report (Date of Earliest Event Reported): May 8, 2007


                                VCA ANTECH, INC.
             (Exact Name of Registrant as Specified in its Charter)


        Delaware                   001-16783                95-4097995
(State or Other Jurisdiction      (Commission              (IRS Employer
      of Incorporation)           File Number)          Identification No.)


                          12401 West Olympic Boulevard
                       Los Angeles, California 90064-1022
               (Address of Principal Executive Offices, Zip Code)

                                 (310) 571-6500
              (Registrant's Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]   Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

[ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

[ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

================================================================================



ITEM 8.01         OTHER EVENTS.

     Reference is made to the press release of VCA Antech, Inc. issued on May 8,
2007, relating to the signing of a definitive merger agreement with Healthy Pet
Corporation, which is incorporated herein by reference. A copy of the press
release is attached hereto as Exhibit 99.1.

     In connection with the acquisition of Healthy Pet Corporation, the Company
currently intends to increase its senior credit facility by $160 million for a
total outstanding amount of $531.7 million in senior term notes.

ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS.

(c)   Exhibits

Exhibit No.       Description
- -----------       -----------

99.1              Press Release issued by VCA Antech, Inc., on May 8, 2007.



                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.



May 8, 2007                              VCA ANTECH, INC.


                                         By:    /s/ Robert L. Antin
                                                -------------------
                                         Name:    Robert L. Antin
                                         Title:   Chief Executive Officer





                                  EXHIBIT INDEX




Exhibit No.       Description
- -----------       -----------

99.1              Press Release issued by VCA Antech, Inc., on May 8, 2007.

EX-99.1

                                                                    Exhibit 99.1

        VCA Antech, Inc. Announces Definitive Merger Agreement


    LOS ANGELES--(BUSINESS WIRE)--May 8, 2007--VCA Antech, Inc.
(NASDAQ:WOOF), a leading animal healthcare company in the United
States, today announced the signing of a definitive merger agreement
with Healthy Pet Corporation ("Healthy Pet"). Under the agreement, VCA
Antech, Inc. ("Company") will acquire Healthy Pet for $152.9 million
(less assumed debt and subject to adjustment for working capital
items) to be paid in cash. Healthy Pet operates 44 animal hospitals
with annual revenue of approximately $80.0 million. On completion of
the merger, the combined companies will operate more than 430 animal
hospitals in 38 states.

    Bob Antin, Chairman and CEO of VCA Antech, Inc., stated, "We
believe that the combination of VCA Antech, Inc. and Healthy Pet
provides a great strategic fit and an opportunity to expand in certain
states, particularly Massachusetts, Connecticut, Virginia and Georgia.
Healthy Pet also operates several specialty and teaching facilities
that will help support our focus on continuing education in the
Northeast.

    "In addition, we believe the opportunity to continue to acquire
individual animal hospitals remains strong. We currently anticipate
that animal hospital acquired revenue for 2007 (exclusive of our
acquisition of Healthy Pet) will range from $50.0 million to $55.0
million.

    "We believe the combination of the two companies will be slightly
accretive to net income and diluted earnings per share beginning in
2008. The impact of the combination (including integration costs of
$1.5 million to $2.0 million) on net income and diluted earnings per
share for the remainder of 2007 is not expected to be material."

    Mr. Gino Volpacchio, President and CEO of Healthy Pet, said, "I am
proud of what we built over the past six years. I view this as a
merger of hospitals, people and cultures and believe it is a great
fit. It is really a continuation of our original vision. The size and
scale of the combined animal hospital operations will afford our
hospitals many benefits and advance our objective of providing the
highest quality veterinary care in the nation."

    The merger agreement was unanimously approved by the VCA Antech,
Inc. and Healthy Pet Board of Directors. The merger agreement is
subject to customary closing conditions. The parties are subject to a
confidentiality agreement. No further details related to the
combination of the two companies will be provided until the closing of
the merger, which is targeted for June 2007.

    This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including the statements as to the expected growth, innovation and
other benefits of the combination of the two companies, expected
impact of the merger on net income and earnings per diluted share for
each of 2007 and 2008, the anticipated timeframe for the closing, and
whether the satisfaction of the closing conditions will be met and the
merger consummated. Actual results may vary substantially as a result
of a variety of factors. Among the important factors that could cause
actual results to differ are: the ability of the companies to satisfy
the conditions to the closing of the merger; the ability of the
Company to obtain the consent of its lenders; the ability of the
companies to consummate the merger; a material adverse change in the
financial condition or operations of either company; the ability to
successfully integrate the two companies and achieve expected
operating synergies following the merger; the rate of the Company's
laboratory internal revenue growth and animal hospital same-store
revenue growth; the level of direct costs and the ability of the
Company to maintain revenue at a level necessary to maintain expected
operating margins; the level of selling, general and administrative
costs; the effects of the Company's recent acquisitions and its
ability to effectively manage its growth and achieve operating
synergies; a continued decline in demand for some of the Company's
products and services; any disruption in the Company's information
technology systems or transportation networks; the effects of
competition; any impairment in the carrying value of the Company's
goodwill; changes in prevailing interest rates; the Company's ability
to service its debt; and general economic conditions. These and other
risk factors are discussed in the Company's periodic reports filed
with the Securities and Exchange Commission, including the Company's
Report on Form 10-K for the year ended December 31, 2006, and the
reader is directed to these statements for a further discussion of
important factors that could cause actual results to differ materially
from those in the forward-looking statements.

    VCA Antech, Inc. owns, operates and manages the largest networks
of freestanding veterinary hospitals and veterinary-exclusive clinical
laboratories in the country, and supplies diagnostic imaging equipment
to the veterinary industry.


    CONTACT: VCA Antech, Inc.
             Bob Antin, 310-571-6500